摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲基-2-苯基-1,3-噻唑-5-甲腈 | 830330-33-1

中文名称
4-甲基-2-苯基-1,3-噻唑-5-甲腈
中文别名
——
英文名称
4-methyl-2-phenylthiazole-5-carbonitrile
英文别名
4-Methyl-2-phenyl-1,3-thiazole-5-carbonitrile
4-甲基-2-苯基-1,3-噻唑-5-甲腈化学式
CAS
830330-33-1
化学式
C11H8N2S
mdl
——
分子量
200.264
InChiKey
KCPBBFJBDVUEIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    376.1±34.0 °C(Predicted)
  • 密度:
    1.25±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    64.9
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934100090

SDS

SDS:6b01d56d895facb681dcd701f1be319d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-甲基-2-苯基-1,3-噻唑-5-甲腈 在 sodium hydrosulfide hydrate 、 magnesium(II) chloride hexahydrate 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 3.5h, 生成 4-(4-chlorophenyl)-4′-methyl-2′-phenyl-2,5′-bithiazole
    参考文献:
    名称:
    Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives
    摘要:
    A series of 4-aryl-4'-methyl-2'-aryl-2,5'-bisthiazole derivatives (5a-o) were synthesized and screened for inhibitory activity against Mycobacterium tuberculosis H37Ra (ATCC 25177) and Mycobacterium bovis BCG (ATCC 35743) strains. Five lead compounds (5e, 5f, 5g, 5h, and 5o) were further confirmed from their dose dependent effect against MTB and Bovine-Calmette-Guerin. The most promising compounds 5f (MIC90: 11.32 mu g/mL), 5h (MIC90: 11.59 mu g/mL), and 5o (MIC90: 23.64 mu g/mL) showed strong antitubercular activity against dormant MTB and BCG as well as almost insignificant cytotoxicity up to 100 mu g/mL against HeLa, A549, and PANC-1 human cancer cell lines. Further, the synthesized compounds were found to have potential antibacterial activity against Gram-negative bacteria, Escherichia coli, Pseudomonas flurescence and Gram-positive bacteria, Staphylococcus aureus, Bacillus subtilis. Most of the synthesized compounds showed moderate activity against fungal strain Candida albicans. Molecular docking studies of these compounds showed significant interactions with crystal structure of the cytochrome P45014 alpha-sterol demethylase (CYP51) PDB ID: 1E9X. Hydrogen bond interactions with SER261 and VAL395 are important interactions for selective inhibition of designed inhibitors. Compounds 5f, 5h, and 5o showed significant interactions with 1E9X. All the experimental results promote us to consider this series as a starting point for the development of novel, selective and more potent antitubercular agents in the future.
    DOI:
    10.1007/s00044-017-1988-5
  • 作为产物:
    描述:
    4-甲基-2-苯基-1,3-噻唑-5-甲醛ammonium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 6.0h, 以78%的产率得到4-甲基-2-苯基-1,3-噻唑-5-甲腈
    参考文献:
    名称:
    4“-甲基-2,2”-二芳基-4,2':4',5“-噻唑衍生物的合成,表征和抗菌筛选
    摘要:
    合成了一系列新颖的4“-甲基-2,2”-二芳基-4,2':4',5“-叔噻唑(8a-p)衍生物,并筛选了对四种病原细菌,大肠杆菌,假单胞菌荧光,金黄色葡萄球菌和枯草芽孢杆菌。其中,化合物8a和8j表现出优异的抗菌活性,最小抑菌浓度范围为1.0至5.3μg/ mL,化合物8m和8p对所有测试菌株均表现出中等至良好的抗菌活性,最小抑菌浓度范围为16.9至29.7μg/ mL。筛选了所有合成的化合物对念珠菌的体外抗真菌活性。大多数化合物报告中等的抗真菌活性。这项研究为我们正在进行的合理设计更有效的抗菌剂的努力提供了有价值的指导。
    DOI:
    10.1002/jhet.3170
点击查看最新优质反应信息

文献信息

  • Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives
    作者:Yogita K. Abhale、Abhijit D. Shinde、Keshav K. Deshmukh、Laxman Nawale、Dhiman Sarkar、Prafulla B. Choudhari、Santosh S. Kumbhar、Pravin C. Mhaske
    DOI:10.1007/s00044-017-1988-5
    日期:2017.11
    A series of 4-aryl-4'-methyl-2'-aryl-2,5'-bisthiazole derivatives (5a-o) were synthesized and screened for inhibitory activity against Mycobacterium tuberculosis H37Ra (ATCC 25177) and Mycobacterium bovis BCG (ATCC 35743) strains. Five lead compounds (5e, 5f, 5g, 5h, and 5o) were further confirmed from their dose dependent effect against MTB and Bovine-Calmette-Guerin. The most promising compounds 5f (MIC90: 11.32 mu g/mL), 5h (MIC90: 11.59 mu g/mL), and 5o (MIC90: 23.64 mu g/mL) showed strong antitubercular activity against dormant MTB and BCG as well as almost insignificant cytotoxicity up to 100 mu g/mL against HeLa, A549, and PANC-1 human cancer cell lines. Further, the synthesized compounds were found to have potential antibacterial activity against Gram-negative bacteria, Escherichia coli, Pseudomonas flurescence and Gram-positive bacteria, Staphylococcus aureus, Bacillus subtilis. Most of the synthesized compounds showed moderate activity against fungal strain Candida albicans. Molecular docking studies of these compounds showed significant interactions with crystal structure of the cytochrome P45014 alpha-sterol demethylase (CYP51) PDB ID: 1E9X. Hydrogen bond interactions with SER261 and VAL395 are important interactions for selective inhibition of designed inhibitors. Compounds 5f, 5h, and 5o showed significant interactions with 1E9X. All the experimental results promote us to consider this series as a starting point for the development of novel, selective and more potent antitubercular agents in the future.
  • Synthesis, Characterization, and Antimicrobial Screening of 4″-methyl-2,2″-diaryl-4,2′:4′,5″-terthiazole Derivatives
    作者:Jitendra Nalawade、Pravin C. Mhaske、Abhijit Shinde、Sachin V. Patil、Prafulla B. Choudhari、Vivek D. Bobade
    DOI:10.1002/jhet.3170
    日期:2018.6
    antibacterial activity with minimum inhibitory concentration range of 16.9 to 29.7 μg/mL against all tested strains. All the synthesized compounds were screened for their in vitro antifungal activity against Cocinida candida. Most of the compounds reported moderate antifungal activity. This study provides valuable directions to our ongoing endeavor of rationally designing more potent antimicrobial agent.
    合成了一系列新颖的4“-甲基-2,2”-二芳基-4,2':4',5“-叔噻唑(8a-p)衍生物,并筛选了对四种病原细菌,大肠杆菌,假单胞菌荧光,金黄色葡萄球菌和枯草芽孢杆菌。其中,化合物8a和8j表现出优异的抗菌活性,最小抑菌浓度范围为1.0至5.3μg/ mL,化合物8m和8p对所有测试菌株均表现出中等至良好的抗菌活性,最小抑菌浓度范围为16.9至29.7μg/ mL。筛选了所有合成的化合物对念珠菌的体外抗真菌活性。大多数化合物报告中等的抗真菌活性。这项研究为我们正在进行的合理设计更有效的抗菌剂的努力提供了有价值的指导。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺